We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
HHS has notified Acambis that it would no longer consider the firm for a contract under the U.S. government’s modified vaccinia ankara (MVA) smallpox vaccine tender process.
Industry groups are criticizing a recent activist report on the state of the Medicare prescription drug plan as a ploy to get direct government negotiation of Medicare costs, a move which they say will limit consumers’ choices.
Industry groups are criticizing a recent activist report on the state of the Medicare prescription drug plan as a ploy to get direct government negotiation of Medicare costs, a move which they say will limit consumers’ choices.
The Secretary’s Advisory Committee on Human Research Protections (SACHRP) is in need of new leadership, as Ernest Prentice is stepping down as chairman.
The Secretary’s Advisory Committee on Human Research Protections (SACHRP) is in need of new leadership, as Ernest Prentice is stepping down as chairman.
The HHS’ Office of Inspector General (OIG) is focusing on ways the federal government can reduce the amount it spends for prescription drugs under Medicaid, including greater use of generics, a high-ranking OIG official says.
The HHS’ Office of Inspector General (OIG) is focusing on ways the federal government can reduce the amount it spends for prescription drugs under Medicaid, including greater use of generics, a high-ranking OIG official says.
Eli Lilly developed fraudulent practice guidelines based on limited data, input from researchers with financial conflicts and the work of industry front groups to increase sales of its sepsis treatment Xigris, according to three NIH investigators.
Observers on all sides of the dispute over Medicare coverage of certain compounded drugs are anxiously awaiting the Centers for Medicare & Medicaid Services’ (CMS) decision about what factors will be considered in setting reimbursement rates.